Is Johnson & Johnson overvalued?

Johnson & Johnson (JNJ) looks overvalued — trading about 14% above its fair value.

Overvalued

Price

$254.66

Fair value

$219.55

Current P/E

23.1

Normal P/E

19.9

Market cap

$613.02B

Dividend yield

2.5%

Return on equity

32.9%

Sector

Healthcare

Fair value compares JNJ's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks